KARDEGIC 300 mg, powder for oral solution in a sachet 30 sachets
Active ingredients: Aspirin, Aspirin DL-lysine
Commercialized according to BDPM
Powder for oral solution30 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KARDEGIC 300 mg, poudre pour solution buvable en sachet
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 30 sachet(s) papier aluminium polyéthylène
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention, après un premier accident ischémique myocardique ou cérébral lié à l¿athérosclérose, d'une récidive. ; JOURNAL OFFICIEL ; 01/08/93
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1993
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68815221CIP73322655CIP133400933226558Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ACÉTYLSALICYLIQUEpoudre | 300 mg · un sachet de 613,8 mg | FT |
| DL-LYSINE (ACÉTYLSALICYLATE DE)poudre | 540 mg · un sachet de 613,8 mg | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.